Pfizer Will Pay $60M To End Foreign Bribery Probes
The agreements resolve Foreign Corrupt Practices Act investigations by both the U.S. Department of Justice and the U.S. Securities and Exchange Commission. Pfizer first came forward with the possible violations in a voluntary disclosure to federal officials in October 2004.
"Pfizer subsidiaries in several countries had bribery so...
To view the full article, register now.